Sickle cell lab support for NHS England goes to Oxford University Hospitals
- NHS England
- London
- Below threshold - without competition
- 1 February 2027 to 31 March 2028
Oxford University Hospitals NHS Foundation Trust will give clinical support to sickle cell and thalassaemia screening laboratories for NHS England.
The trust will advise antenatal and newborn screening labs, and other staff working in the Sickle Cell and Thalassaemia Programme, by telephone and email. Its advice must follow the latest National Screening Programme policy and standards. It will also hold two meetings a year with the Programme Centre and take part in twice-yearly workshops.
NHS England awarded the £37,715 contract directly, with no competition. The work will run from February 2027 to March 2028.
Contract ends March 2028
- What
- Screening and population testing programmes
- Buyer
- NHS England
- Value
- £37,715
- How it was bought
- Below threshold - without competition
- Dates and next
- Feb 2027 to Mar 2028